CXCL5 and breast carcinoma: Since activation of ERK signaling has been associated with CXCL5-promoted malignancy in breast cancer26, we applied PD98059, a potent inhibitor for ERK phosphorylation35, to investigate its influence on breast cancer cell migration in the co-culture model.